Clinical Trial Testing TH-302 in Combination With Gemcitabine in Previously Untreated Subjects With Metastatic or Locally Advanced Unresectable Pancreatic Adenocarcinoma

NCT01746979 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

693

Enrollment

INDUSTRY

Sponsor class

Conditions

Metastatic or Locally Advanced Unresectable Pancreatic Adenocarcinoma

Interventions

DRUG: TH-302
DRUG: Gemcitabine
DRUG: Placebo (5 percent dextrose - D5W)

Sponsor

ImmunoGenesis

Collaborators

[object Object]